Most of our posts focus on specific health or medical technologies. IDTechEx recently published a report on the future of cardiovascular disease management. The report stresses the importance of wearable and nonwearable biometric sensors in remote monitoring and telemedicine. The report, “Cardiovascular Disease 2020-2030: Trends, Technologies, & Outlook” elaborates on the positive changes in patient care that are now possible through remote patient monitoring (RPM).
RPM implementation with cardiac disease patients means neither patients nor healthcare professionals need to travel as much as with traditional treatments. Rather than checking in at a hospital, clinic, or doctor’s office, patients can communicate with doctors and other medical staff via portals and televideo calls. Continuous vital sign monitoring with wearable or nonwearable biometric tracking devices can give clinicians better insight into patient vital signs throughout daily activities, compared with anecdotal in-office measurements. Remote monitoring systems can also alert care teams of patient emergencies or change in conditions that require timely attention. The ability to intervene quickly can potentially head off medical problems before they get worse, save trips to the emergency department, and reduce hospital admissions and re-admissions.
According to IDTechEX, other potential RPM benefits include improved patient adherence, clinical trial monitoring, pre- and post-op monitoring, and predicting and preventing cardiac events. Specific CVDs appropriate for RPM include hypertension, heart failure, and arrhythmias. Overall, IDTechEx reports that RPM tech helps change CVD management procedures and routines through increased healthcare delivery efficiency and accessibility.
